Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-053435
Filing Date
2019-10-17
Accepted
2019-10-17 16:50:05
Documents
1
Period of Report
2019-10-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8242
  Complete submission text file 0001209191-19-053435.txt   9697
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTRA-CELLULAR THERAPIES, INC. 430 EAST 29TH STREET NEW YORK NY 10016
Business Address
Neumann Mark (Reporting) CIK: 0001756211 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36274 | Film No.: 191155607